Review of management issues in relapsed osteosarcoma (Q38168922)

30 August 2017

title

Review of management issues in relapsed osteosarcoma (English)

1 reference

30 August 2017

author name string

Nataraj Vijayamurugan

series ordinal

1

1 reference

30 August 2017

Sameer Bakhshi

series ordinal

2

1 reference

30 August 2017

publication date

26 November 2013

1 reference

Expert Review of Anticancer Therapy

30 August 2017

published in

1 reference

30 August 2017

volume

14

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

151-161

1 reference

Common musculoskeletal tumors of childhood and adolescence

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Multiple pulmonary resections in the treatment of osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Primary bone osteosarcoma in the pediatric age: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Patterns of recurrence after resection of osteosarcoma of the extremity. Strategies for treatment of metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

The patterns of relapse in osteosarcoma: the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

The metastatic patterns of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Results of thoracotomy in osteogenic sarcoma with pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Aggressive thoracotomy for pulmonary metastatic osteogenic sarcoma in children and young adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Survival after recurrence of osteosarcoma: a 20-year experience at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

High-dose ifosfamide in relapsed pediatric osteosarcoma: therapeutic effects and renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcoma of the extremities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

The effect of local recurrence on survival in resected osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Metachronous multifocal osteosarcoma: a case report and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Single and multiple metachronous osteosarcoma tumors after therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Resection of recurrent pulmonary metastases in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Ezrin, a key component in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Increased Fas expression reduces the metastatic potential of human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Fas expression in lung metastasis from osteosarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Bioactive hydrogels with enhanced initial and sustained cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

VEGF expression as a prognostic marker in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.863453

10.1586/14737140.2014.863453

21 January 2018

Identifiers

DOI

1 reference

release_bbhyksg53zgpnjanld5om3zfge

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bbhyksg53zgpnjanld5om3zfge

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference